Section Arrow
CADL.NASDAQ
- Candel Therapeutics
Quotes are at least 15-min delayed:2024/05/16 07:54 EDT
Last
 14
+3.3 (+30.84%)
Day High 
14.28 
Prev. Close
10.7 
1-M High
10.88 
Volume 
1.71M 
Bid
14.52
Ask
14.65
Day Low
10.725 
Open
10.83 
1-M Low
5.05 
Market Cap 
314.02M 
Currency USD 
P/E -- 
%Yield
10-SMA 9.49 
20-SMA 7.74 
50-SMA 4.86 
52-W High 14.28 
52-W Low 0.66 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.31/-0.88
Enterprise Value
327.37M
Balance Sheet
Book Value Per Share
0.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 07:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.